Frédéric Guyon is an expert in Oncology at Institut Bergonié (France). Frédéric Guyon has authored 229 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 5 of them ongoing. SLR score: 562 (community average: 125). How the SLR is computed.

LeadR Profile

Frédéric Guyon Institut Bergonié France
562 ScienceLeadR Reputation 562
Network Map

Oncology

Subspecialties: Gynecology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1996 - 2026

Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 229

Citations

Citations: 5 276 1st author: 16 Last author: 28 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network.
PMID 42411723 — cytoreduction surgical procedures, ovary, neoplasms, ovarian neoplasms
J Gynecol Oncol20260
Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.
PMID 42361574 — cytoreduction surgical procedures, ovary, genital neoplasms, female, retrospective studies, ovarian neoplasms
Gynecol Oncol20260
Comparison of sentinel lymph node mapping with comprehensive lymphadenectomy in p53-mutated endometrial cancer: a prospective, multi-center, non-inferiority, open-label, de-escalation, randomized, controlled trial (Study Protocol - SENTIMETREP53).
PMID 41796475 — lymph nodes, tomography, lymph node excision, positron-emission tomography, genital neoplasms, female, neoplasms, multiple chronic conditions, classification, sentinel lymph node, positron emission tomography computed tomography, genes, p53, lymph, morbidity, therapeutics, mutation, endometrial neoplasms
Int J Gynecol Cancer20260
Fertility preservation in gynecologic oncology: evaluating knowledge, practices, and barriers among French healthcare providers.
PMID 41494211 — fertility, genital neoplasms, female, fertility preservation, cryopreservation, oocytes, health personnel, tissues, reproductive medicine
Int J Gynecol Cancer20250
Adjuvant Treatment for Surgically-Treated Cervical Cancer Patients: A Comprehensive Review.
PMID 41301072 — uterine cervical neoplasms, neoplasms, therapeutics
Cancers (Basel)20250

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 9
Phase 3 2

By status:

Active not recruiting 5
Not yet recruiting 2
Recruiting 2
Completed 1
Unknown 1

By type:

Interventional 9
Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 5

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53 Mutated Endometrial Cancer A Non Inferiority Randomized Trial
NCT06900582 — genes, lymph nodes, lymph node excision, ureter, neoplasms, sentinel lymph node, biopsy, arteries, genes, p53, lymph, tissues, ligaments, sentinel lymph node biopsy, indocyanine green, anatomy, iliac artery, mutation, dissection, endometrial neoplasms, cervix uteri
N/ANot yet recruiting2026
Risk reducing Strategies Including Fimbriectomy in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
NCT06726330 — sterilization, menopause, premature, surgical procedures, operative, genetic predisposition to disease, ovary, cardiovascular diseases, neoplasms, cognitive dysfunction, sterilization, tubal, germ-line mutation, osteoporosis, ovarian neoplasms, patient preference, prophylactic surgical procedures, menopause, tissues, genes, brca1, salpingo-oophorectomy, mutation, pelvic neoplasms, fallopian tubes, ovariectomy, carcinoma, women
N/ANot yet recruiting2027
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
NCT06392997 — genital diseases, female, endometriosis, uterine cervical neoplasms, ovary, genital neoplasms, female, neoplasms, pathology, cysts, ovarian neoplasms, leiomyoma, uterine neoplasms, rna, genital diseases, female
N/ARecruiting2024
PARa aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121 — radiotherapy, carcinoma, adenosquamous, lymph nodes, lymph node excision, uterine cervical neoplasms, brachytherapy, neoplasms, adenocarcinoma, laparoscopy, human papillomavirus 16, lymph, therapeutics, carcinoma
Phase 3Recruiting2023
Diagnostic Performances of Preoperative Echo guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR)
NCT04250766 — anesthesia, fibroma, pain, pain measurement, uterus, radiologists, neoplasms, biopsy, sarcoma, anesthesia, local, leiomyoma
N/AActive not recruiting2021

LeadR Networks

Main global connection map